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Abstract
We here propose a novel Raman spectroscopy method that permits the noninvasive measurement of blood glucose
concentration. To reduce the effects of the strong background signals produced by surrounding tissue and to obtain the
fingerprint Raman lines formed by blood analytes, a laser was focused on the blood in vessels in the skin. The Raman
spectra were collected transcutaneously. Characteristic peaks of glucose (1125 cm-1) and hemoglobin (1549 cm-1) were
observed. Hemoglobin concentration served as an internal standard, and the ratio of the peaks that appeared at 1125 cm-1
and 1549 cm-1 peaks was used to calculate the concentration of blood glucose. We studied three mouse subjects whose
blood glucose levels became elevated over a period of 2 hours using a glucose test assay. During the test, 25 Raman spectra
were collected transcutaneously and glucose reference values were provided by a blood glucose meter. Results clearly
showed the relationship between Raman intensity and concentration. The release curves were approximately linear with
a correlation coefficient of 0.91. This noninvasive methodology may be useful for the study of blood glucose in vivo.
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Introduction
Diabetes mellitus is rapidly increasing in global incidence.
According to the World Health Organization (WHO), there were
over 171 million diabetics worldwide in 2000 (2.8% of the
population). It is projected that the number of patients will
increase to 366 million by 2030 [1]. Diabetes mellitus is a chronic
and incurable disease caused by the malfunction of insulin
production, which affects the concentration of glucose in the
blood [1]. Glucose is the body’s primary energy source, and
unregulated blood glucose concentrations can cause many medical
complications. Today, diabetes is diagnosed by measurement of
blood sugar levels. Diabetics need to supervise their glucose levels
closely and measure them several times a day [2].
The current approach uses small blood volumes extracted from
the finger, palms, thighs, forearms, or abdomen to measure
glucose. Various alternative sensor devices that would allow
doctors and patients to measure glucose levels precisely without
the discomfort of extracting blood samples have been proposed
and implemented [3]. Repeated drawing of blood can induce
substantial pain and increase the risk of infection. It also incurs
significant costs due to the number of test strips required. In that
sense, non-invasive glucose meters represent a major breakthrough
[4]. Optical methods have been proposed as a painless and
accurate means of glucose measurement [5,6].
Existing non-invasive optical techniques include near infrared
spectroscopy, Raman spectroscopy, photo-acoustic spectroscopy,
femtosecond pulse interferometry, optical coherence tomography,
and different types of fluorescence [7–26]. Common limitations of
these approaches include poor glucose specificity and sensitivity
and interference from background species. NIR Raman spectros-
copy has successful measured glucose at physiologically relevant
concentrations in serum, whole blood, and even in interstitial fluid
of human volunteers [28–31].
However, there is no clinically accurate and robust algorithm
that can predict glucose concentrations in multiple human subjects
or in the same subject at different times [25]. The physiological lag
between blood and interstitial fluid (ISF) glucose is a major
challenge for non-invasive measurements of glucose concentration.
This is a particular problem with spectroscopic techniques, which
predominantly probe ISF glucose, creating inconsistencies in the
calibration of methods in which blood glucose is used as a reference
[23]. To overcome this problem, many research groups have used
arithmetic techniques such as dynamic concentration correction
(DDC) and partial least squares (PLS) [23,27]. However, accuracy
remains low for spectra based on combinations of skin heteroge-
neity and glucose kinetics parameters. Chaiken used tissue-
modulated Raman spectroscopy to noninvasively measure blood
glucose concentration [31]. In the present study, the measurement
sequence consisted of an unpressed and a pressed state. In the
unpressed state, the measured Raman spectrum included con-
tributions from both tissue components and blood analytes. In the
pressed state, pressure placed on the finger causes much of the
blood to leave the irradiated capillary bed. Raman spectra
measured under these conditions tend to show lower peaks. The
glucose concentration can be calculated using these Raman
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spectra. In the unpressed state, spectra may be affected by actors
such as displacement and blood in the capillaries.
Here, we report a novel Raman spectroscopy method suitable
for transcutaneous monitoring of glucose concentration using
focused lasers on blood in vessels in the skin to directly assess blood
Raman spectra. We determined the background spectra near the
vessels. This method can solve the problems mentioned above. We
used hemoglobin as an internal standard. The ratio of the height
of peaks appearing at 1125 cm-1 and at 1549 cm-1 was successfully
used to determine the glucose concentrations in the blood. The
results show that this method can be used for quantitative analysis
of blood glucose. It was found to be highly accurate, strongly
linear, and reproducible.
Materials and Methods
Animal Models
Four-week-old SPF grade Kunming mice weighing 25–35 g,
were purchased from Guangxi Medical University. This study was
performed in strict accordance with the recommendations of the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. The protocol was approved by the Guangxi
Medical University Institutional Animal Care and Use Committee
(Permit Number: 12-215). All experiments were performed under
chloral hydrate anesthesia, and every effort was made to minimize
suffering.
Chemicals
D-glucose was purchased from Sigma Aldrich. Milli-Q water
was used to prepare the glucose solutions at different concentra-
tions throughout the present study.
Raman Measurements
The in vivo Raman setup employed in this study has been
described previously [32]. Fig. 1 depicts the setup. Briefly, a diode
laser operating at 785 nm (DL7140, Sanyo) was used for excitation
of Raman spectra with an average power of about 15 mW at the
sample. The animal subject was anesthetized and placed on the
stage with its ear adhered to a microscope slide. The laser beam
from a diode laser was introduced into the objective of an inverse
Nikon TE-U microscope equipped with a 10061.3 NA oil
immersion objective and focused on the selected blood vessel.
The backscattered light was collected using the microscope
objective; it first passed through a holographic notch filter and
then through a confocal system with a 100 mm pinhole. The
spectrometer had grating at 1200 lines/mm and was fitted with
a thermoelectrically controlled CCD detector (PIXIS 100 BR,
Princeton Instruments), cooled to -120uC. A CCD camera
attached to the microscope provided optical images during
experiments. Raman spectra were recorded with a spectral
resolution of 4 cm-1. To determine the locations of the blood
vessels to be measured, each ear was transilluminated with a white
LED (560 nm) and imaged by the microscope objective lens into
a CCD camera.
Sample Preparation
a) In vitro experiment: Each mouse was given water ad libitum and
no food for 24 hours before the experiment. Glucose (5% wt./wt.)
was injected into each mouse (0.1 ml/10 g) and blood was taken
from the tail 30 min later. Blood samples were collected every 15
minutes. The Raman spectra of blood were taken immediately
after blood collection. Raman spectra of each collection were
found to contain three spectra. All Raman spectrum acquisition
processes lasted 15 s. For reference, blood glucose was also
Figure 1. (A) Experimental setup: A laser beam was introduced into a microscope and focused into the selected blood vessels of
live mice to collect Raman spectra. Backwards Raman scattering light from blood was projected into the entrance slit of a spectrograph. TC,
temperature controller; DL, diode laser; OP, optical isolator; IF, interference filter; M, mirror; L, lens; PH, pinhole; HNF1, HNF2, holographic notch filter;
CCD, charge-coupled detector; DM, dichronic mirror; BS, beam splitter; Obj, objective lens; EP, eyepiece; VC, video camera. b: Laser beam in mouse
ear.
doi:10.1371/journal.pone.0048127.g001
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measured using a blood glucose meter (GT-1810, ARKRAY
Factory, Inc.).
b) In vivo experiment: Each mouse was given water ad libitum and
no food for 24 hours before the experiment, 4% chloral hydrate
(0.1 ml/10 g) was injected into the abdomen of mice to
anaesthetize them. Glucose (5% wt./wt.) was injected into the
anesthetized mice (0.1 ml/10 g). Starting 30 min after the in-
jection of glucose, Raman spectra of the blood in the veins under
the skin were collected every 15 min over a 2 h period. Each
collection produced three spectra. All Raman spectrum acquisition
processes lasted 15 s. Reference blood glucose concentrations were
measured from blood taken from the tail using a blood glucose
meter (GT-1810, ARKRAY Factory, Inc.). In order to provide
data about the reproducibility of the results, three experiments
were performed on three separate mice, and 25 data sets were
obtained. The background spectra were acquired near the vessels.
Data Analysis
Spectral processing included the removal of cosmic ray spikes,
subtraction of background spectra, 5-point adjacent averaging
smoothing, baseline calibration, and averaging of the spectra.
These actions were performed out using Micro Origin 8.0
software.
Results and Discussion
Raman Spectra of Glucose Solutions
Fig. 2 shows the Raman spectra of glucose solutions at different
glucose concentrations. The spectra show the Raman peaks
Figure 2. Raman spectra of glucose solutions. The peaks indicative of glucose increase as function of concentration.
doi:10.1371/journal.pone.0048127.g002
Figure 3. (A) Raman spectra of blood with different glucose concentrations; B: blood.
doi:10.1371/journal.pone.0048127.g003
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characteristic of glucose. These values are consistent with the
standard spectrum [33]. The major Raman peaks that appeared at
911 cm-1, 1060 cm-1, and 1125 cm-1 are considered the Raman
fingerprints of glucose. However, the peak that appeared at
1125 cm-1 was the most intense, meaning that it had the best
signal to noise ratio. Here, we used only the 1125 cm-1 peak to
demonstrate the efficacy of this system. The measurements were
performed using glucose concentrations of 1–400 mmol/dl, and
the intensities of the Raman lines increased as glucose concentra-
tion increased. This suggests that the concentration of blood
glucose can be determined by measuring its Raman spectrum.
However, in practice, the concentration of human blood glucose
can be as low as 3–10 mmol/dl for normal individuals and
,30 mmol/ml for diabetics. The Raman intensity at very low
concentrations is too weak to be measured within a reasonable
time. In our study, no Raman signal was detected at glucose
concentrations below 50 mmol/dl, even exposure lasted as long as
10 minutes. These results are consistent with those observed in one
previous study [34]. We found that changes in Raman intensity
could be observed when glucose was present in the blood.
Raman Spectra of Blood Glucose in vitro
As shown in Fig. 3, the intensities of the Raman lines increased
as the concentration of glucose increased. Because of the
complexity, individuality, and diversity of the tissues surrounding
the blood vessels, an internal standard had to be selected to ensure
that the correct data were collected. The concentration of
hemoglobin is more stable than that of glucose, and intra-species
differences in the concentration of hemoglobin are small. For this
reason, the concentration of hemoglobin was chosen as internal
standard. The relative intensity of glucose was obtained through
normalization of the height of characteristic peaks of hemoglobin
(1549 cm-1). This method can be used to determine the
concentration of glucose in the blood. Blood glucose concentra-
tions determined with the glucose meter and 1125 cm-1 relative
intensity are shown in Table 1.
Concentration-dependent Raman intensities of glucose are
plotted in Fig. 4B using 1125 cm-1 relative intensity. A clear
linear relationship appeared between Raman intensity and
concentration with a mean absolute error (MAE) in the validated
data of 6.7% and an Adj. R-Square of 0.95. This is critical to the
quantitative measurement of blood glucose levels.
Table 1. Blood glucose concentration and 1125 cm-1 relative intensity.
Time (min) Blood glucose concentration (mmol/dl) 1125 cm-1relative intensity
30 4.8 0.240
45 5.6 0.242
60 8.4 0.254
75 12.1 0.258
90 15.9 0.274
105 9.4 0.256
120 7.2 0.252
135 6.5 0.245
150 6.2 0.245
doi:10.1371/journal.pone.0048127.t001
Figure 4. (A) Blood glucose value with 1125 cm-1 relative intensity; 4B Concentration-dependent Raman relative intensities of
glucose (1125 cm-1).
doi:10.1371/journal.pone.0048127.g004
Blood Glucose Quantification
PLOS ONE | www.plosone.org 4 October 2012 | Volume 7 | Issue 10 | e48127
Raman spectra of blood glucose in vivo
The blood vessel was clearly visible under the microscope
(Fig. 5A). Fig. 5B depicts one of the 25 Raman spectra. Fig. 5C
shows the spectra after normalization. Figs. 5B and 5C show that
the intensity of the 1125 cm-1 peaks increases as glucose
concentration increases. In this way, the Raman spectra can
indicate changes in the level of glucose in the blood in vivo.
Blood glucose concentration values depend on the relative
intensity of blood glucose after normalization. The intensity of
hemoglobin from 25 Raman spectra from 3 mice is plotted in
Fig. 6. A clear linear relationship was observed between the
Raman intensity and the concentration. It showed a mean
absolute error (MAE) in the validated data of 5.7% and an Adj.
R-Square of 0.91. Table 2 shows the linearized curve-fitting
parameters of Raman intensity and individual concentration. The
values of slope and intercept from different mice were found to be
similar to each other and to the combined data. These results
indicate good reproducibility.
Many methods of measuring glucose are subject to valid
questions about whether glucose itself is actually being measured.
With this system, however, the presence of glucose was indicated
by a peak at 1125 cm-1. This is direct spectral evidence that the
measurements were produced in response to active glucose
Figure 5. (A) Blood vessel in a mouse ear highlighted by dashed white lines. Scale bar is 10 mm; Fig. 5B: Raman spectra of blood with
different glucose concentrations; Fig. 5C Raman spectra after normalization at a height of 1549 cm-1.
doi:10.1371/journal.pone.0048127.g005
Figure 6. Raman relative intensities of glucose (1125 cm-1) in vivo versus the reference values with a mean absolute error of 5.7%
and an Adj. R-Square of 0.91.
doi:10.1371/journal.pone.0048127.g006
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concentrations. Focusing the laser on the blood in the vessels in the
skin can decrease background signal from tissues. Although
significant scattering and attenuation of the incident light were
caused by interactions with the tissue, these effects were addressed
using background correction. The concentration of hemoglobin
served as internal standard, and it was found to reduce the impact
of complexity, individuality, and diversity of both tissues and
individuals, improving performance. In defined areas, hemoglobin
can be carefully controlled physiologically. In this way, calibration
is a key to this type of measurement.
Conclusion
The Raman spectra of glucose solutions were obtained and
examined. The spectra showed Raman peaks characteristic of
glucose. These peaks can be observed in the blood. A clear linear
relationship (R-squared correlation coefficient of 0.91) was
observed between the Raman intensity and glucose concentration.
To reduce the effect of the strong background signal produced by
the tissue and to determine the fingerprint Raman lines formed by
blood analytes, a laser was focused on the blood in the vessels of
the skin, and the resulting Raman spectra were collected. Using
hemoglobin concentration as an internal standard, the ratio of the
height of 1125 cm-1 against 1549 cm-1 was used to calculate the
concentration of blood glucose. The results showed that this
method can be used for noninvasive, quantitative analysis of blood
glucose in vivo. These measurements were found to be highly
accurate, strongly linear, and reproducible. Although the detection
limit of this technique requires further improvement before it can
meet clinical needs, we expect advances in detector sensitivity and
background correction to compensate for these limitations.
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